SEC Tracker
Get the app

X4 Pharmaceuticals XFOR

X4 Pharmaceuticals secures $150M loan

Form
8-K
Filed
Importance
Routine
  1. Loan of up to $150M with K2 HealthVentures
  2. First tranche of $80M used to repay existing loan
  3. Second tranche of $70M available upon request
  4. Maturity date of October 1, 2030

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when X4 Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Akari Therapeutics AKTX public float $15M, Jun 30, 2025
  2. ProPhase Labs PRPH public float $15M, Jun 30, 2025
  3. Pluri PLUR public float $15M, Dec 31, 2025
  4. CalciMedica CALC public float $16M, Jun 30, 2025
  5. Edesa Biotech EDSA public float $14M, Mar 31, 2025, over 18 months old